We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.27B
AUM Growth
-$27.4M
Cap. Flow
-$19.9M
Cap. Flow %
-1.57%
Top 10 Hldgs %
41.69%
Holding
322
New
24
Increased
70
Reduced
105
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Financials 7.86%
3 Healthcare 7.77%
4 Consumer Discretionary 6.07%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMTH icon
1
ALPS Smith Core Plus Bond ETF
SMTH
$2.93B
$118M 9.29%
4,543,908
+2,699,820
+146% +$69.3M
IBDU icon
2
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.01B
$83M 6.56%
+3,590,158
New +$82.3M
IVV icon
3
iShares Core S&P 500 ETF
IVV
$876B
$57.8M 4.57%
102,933
+38,812
+61% +$22.9M
DCRE icon
4
DoubleLine Commercial Real Estate Debt ETF
DCRE
$453M
$44.4M 3.5%
855,345
+15,995
+2% +$826K
GLW icon
5
Corning
GLW
$126B
$42.1M 3.32%
919,270
-13,176
-1% -$651K
AAPL icon
6
Apple
AAPL
$4.89T
$42M 3.32%
189,201
-1,881
-1% -$436K
MSFT icon
7
Microsoft
MSFT
$2.84T
$41.9M 3.31%
111,606
-565
-0.5% -$230K
LLY icon
8
Eli Lilly
LLY
$1.07T
$37.3M 2.94%
45,114
-600
-1% -$499K
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.07T
$32.5M 2.56%
60,932
-1,706
-3% -$829K
RSP icon
10
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$29.3M 2.32%
169,427
+3,046
+2% +$542K
JPM icon
11
JPMorgan Chase
JPM
$939B
$29.2M 2.31%
119,014
-2,855
-2% -$728K
TMO icon
12
Thermo Fisher Scientific
TMO
$211B
$28.8M 2.27%
57,824
-916
-2% -$496K
IBDR icon
13
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.46B
$26.8M 2.12%
1,108,718
-338,080
-23% -$8.16M
BSCQ icon
14
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.67B
$24.2M 1.91%
1,241,228
-267,154
-18% -$5.2M
QCOM icon
15
Qualcomm
QCOM
$176B
$23M 1.81%
149,580
-1,655
-1% -$270K
TXN icon
16
Texas Instruments
TXN
$255B
$21.8M 1.73%
121,569
-7,133
-6% -$1.34M
AVY icon
17
Avery Dennison
AVY
$12.3B
$21.1M 1.67%
118,795
-420
-0.4% -$77.2K
VO icon
18
Vanguard Mid-Cap ETF
VO
$106B
$20.3M 1.6%
313,688
+45,344
+17% +$3.04M
GDX icon
19
VanEck Gold Miners ETF
GDX
$23B
$18.6M 1.47%
403,552
-131,311
-25% -$5.31M
JCI icon
20
Johnson Controls International
JCI
$87.5B
$18.2M 1.44%
227,356
-49,231
-18% -$4.05M
GLD icon
21
SPDR Gold Trust
GLD
$131B
$18.1M 1.43%
62,893
-20
-0% -$5.29K
IBM icon
22
IBM
IBM
$202B
$18M 1.42%
72,547
-621
-0.8% -$152K
AMZN icon
23
Amazon
AMZN
$2.5T
$15.6M 1.23%
82,148
-444
-0.5% -$96.3K
OPLN
24
Openlane
OPLN
$4.17B
$14.8M 1.17%
767,954
-2,481
-0.3% -$51.2K
CRM icon
25
Salesforce
CRM
$134B
$14.1M 1.12%
52,613
-151
-0.3% -$47K

Similar funds

Shufro Rose & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Shufro Rose & Co held 322 positions worth $1.27B, down 2.1% from $1.29B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Shufro Rose & Co's Q1 2025 filing shows 24 new, 70 increased, 105 reduced and 8 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 3,590,158 shares worth $83M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $81.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Shufro Rose & Co's largest Q1 2025 buy was iShares iBonds Dec 2029 Term Corporate ETF: 3,590,158 shares worth $83M.
  • Shufro Rose & Co added most to ALPS Smith Core Plus Bond ETF in Q1 2025, an estimated $69.3M increase.
  • Shufro Rose & Co's biggest Q1 2025 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $81.7M.
  • Shufro Rose & Co fully exited iShares iBonds Dec 2026 Term Treasury ETF in Q1 2025, selling an estimated $738K.
  • Shufro Rose & Co's ten largest holdings make up 42% of its $1.27B portfolio in Q1 2025.
  • Shufro Rose & Co opened 24 new positions and closed 8 in Q1 2025.
  • Shufro Rose & Co's portfolio value fell 2.1% quarter-over-quarter to $1.27B.

Based on Shufro Rose & Co's 13F filing for Q1 2025, filed 8 May 2025.